Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Clinical trial NCT07698535 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07698535
- Sponsor
- University of Washington
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2029-07-05
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.